Andere Kunden interessierten sich auch für
![Complementary and Alternative Medicine in Rheumatology, An Issue of Rheumatic Disease Clinics]( "Complementary and Alternative Medicine in Rheumatology, An Issue of Rheumatic Disease Clinics")
Complementary and Alternative Medicine in Rheumatology, An Issue of Rheumatic Disease Clinics69,99 €![Controversies in Rheumatology, an Issue of Rheumatic Disease Clinics of North America]( "Controversies in Rheumatology, an Issue of Rheumatic Disease Clinics of North America")
Controversies in Rheumatology, an Issue of Rheumatic Disease Clinics of North America81,99 €![Education and Professional Development in Rheumatology, an Issue of Rheumatic Disease Clinics of North America]( "Education and Professional Development in Rheumatology, an Issue of Rheumatic Disease Clinics of North America")
Education and Professional Development in Rheumatology, an Issue of Rheumatic Disease Clinics of North America75,99 €![Best Practices and Challenges to the Practice of Rheumatology, an Issue of Rheumatic Disease Clinics of North America]( "Best Practices and Challenges to the Practice of Rheumatology, an Issue of Rheumatic Disease Clinics of North America")
Best Practices and Challenges to the Practice of Rheumatology, an Issue of Rheumatic Disease Clinics of North America81,99 €![Pediatric Rheumatology, An Issue of Rheumatic Disease Clinics]( "Pediatric Rheumatology, An Issue of Rheumatic Disease Clinics")
Pediatric Rheumatology, An Issue of Rheumatic Disease Clinics59,99 €![Pediatric Rheumatology, An Issue of Pediatric Clinics]( "Pediatric Rheumatology, An Issue of Pediatric Clinics")
Pediatric Rheumatology, An Issue of Pediatric Clinics55,99 €![New Insights Into Rheumatoid Arthritis, an Issue of Rheumatic Disease Clinics]( "New Insights Into Rheumatoid Arthritis, an Issue of Rheumatic Disease Clinics")
New Insights Into Rheumatoid Arthritis, an Issue of Rheumatic Disease Clinics61,99 €
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.